These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 22048598

  • 1. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY, Poonja LS.
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [Abstract] [Full Text] [Related]

  • 2. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zöller J, Bosch FX, Zöller M.
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [Abstract] [Full Text] [Related]

  • 3. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S, Ott A, Berghold A, Beham A.
    J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
    [Abstract] [Full Text] [Related]

  • 4. CD44s and CD44v6 expression in head and neck epithelia.
    Mack B, Gires O.
    PLoS One; 2008 Jan; 3(10):e3360. PubMed ID: 18852874
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
    Lu D, Tawfik O, Pantazis C, Hobart W, Chapman J, Iczkowski K.
    Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
    [Abstract] [Full Text] [Related]

  • 6. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
    Ashida K, Terada T, Kitamura Y, Kaibara N.
    Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
    [Abstract] [Full Text] [Related]

  • 7. Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse.
    Beham-Schmid C, Heider KH, Hoefler G, Zatloukal K.
    J Pathol; 1998 Dec; 186(4):383-9. PubMed ID: 10209487
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A, Krassort M, Buchwalow IB, Végh A, Felszeghy E, Piffkó J.
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of CD44 molecule in renal cell carcinoma.
    Lucin K, Matusan K, Dordević G, Stipić D.
    Croat Med J; 2004 Dec; 45(6):703-8. PubMed ID: 15578803
    [Abstract] [Full Text] [Related]

  • 12. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis.
    Kasper M, Günthert U, Dall P, Kayser K, Schuh D, Haroske G, Müller M.
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):648-56. PubMed ID: 7576702
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H.
    Cancer Res; 1993 Sep 15; 53(18):4197-203. PubMed ID: 7689929
    [Abstract] [Full Text] [Related]

  • 14. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA, van Steenbrugge GJ, Verkaik NS, Schröder FH, van der Kwast TH.
    Clin Cancer Res; 1997 May 15; 3(5):805-15. PubMed ID: 9815753
    [Abstract] [Full Text] [Related]

  • 15. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R, Hirvikoski P, Böhm J, Kellokoski J, Moisio K, Virén M, Johansson R, Hollmén S, Kosma VM.
    Hum Pathol; 2000 Sep 15; 31(9):1088-95. PubMed ID: 11014576
    [Abstract] [Full Text] [Related]

  • 16. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis?
    Fasano M, Sabatini MT, Wieczorek R, Sidhu G, Goswami S, Jagirdar J.
    Cancer; 1997 Jul 01; 80(1):34-41. PubMed ID: 9210706
    [Abstract] [Full Text] [Related]

  • 17. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H.
    Gynecol Oncol; 1995 Jun 01; 57(3):383-7. PubMed ID: 7539775
    [Abstract] [Full Text] [Related]

  • 18. Heat shock proteins (HSP70 and HSP27) as markers of epithelial dysplasia in oral leukoplakia.
    Seoane JM, Varela-Centelles PI, Ramirez JR, Cameselle-Teijeiro J, Romero MA, Aguirre JM.
    Am J Dermatopathol; 2006 Oct 01; 28(5):417-22. PubMed ID: 17012917
    [Abstract] [Full Text] [Related]

  • 19. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS, del Rosario AD, Bui HX, Kallakury BV, Okby NT, Figge J.
    Mod Pathol; 1996 Aug 01; 9(8):854-60. PubMed ID: 8871928
    [Abstract] [Full Text] [Related]

  • 20. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
    Kuo MY, Cheng SJ, Chen HM, Kok SH, Hahn LJ, Chiang CP.
    J Oral Pathol Med; 1998 Oct 01; 27(9):428-33. PubMed ID: 9790096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.